Sponsored content brought to you by The advent of multiomic approaches has significantly improved early cancer detection by ...

A robust and efficient protein biomarker development pipeline helps scientists overcome common challenges associated with ...

Multiplex: If users are interested ... enables rapid Simoa® assay prototyping with enhanced biomarker detection and ease of use compared to standard ELISA. The development process occurs in ...

“The Bio-Plex Pro Human Cytokine Screening Panel has been validated to deliver more accurate data points within assay range than similar multiplex assays on the ... to make actionable decisions in ...

The firm is developing a kitted version of the four-biomarker combination test, and it plans to commercialize them in the EU and US markets.

While spatial biomarkers and AI offer transformative potential, there are hurdles to overcome. Multiplex immunofluorescence, a leading spatial analysis tool, requires robust pipelines to handle the ...

"The Custom Assay Development Kit is a direct response to the growing demand from researchers eager to harness our cutting-edge NULISA technology to develop high-performance biomarker assays for ...

In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell ...

They performed an RNA sequencing analysis ... biomarker tests, including serum PSA alone, the Prostate Cancer Prevention Trial risk calculator, the Prostate Health Index (PHI), and derived ...

The Simoa® Human Neurology 4-Plex E (N4PE) assay concurrently detects four biomarkers in EDTA plasma and CSF. These targets include amyloid beta 40 (Aβ40), amyloid beta 42 (Aβ42), Glial ...